Statistics
Publications
1
Citations
10
H-Index
1
Active since
2023
Affiliations
Tianjin Hospital(Current)
Bi Meng is an author at Tianjin Hospital specializing in cd8 positive t cells, targeted cancer therapy, and targeted therapy.
Publications per year
2023–2023
1
1
AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses
Bi Meng, Xuan Zhao, Shuchang Jiang et al. · Frontiers in Immunology · 2023 · 10 citations · Full text
Medicine, Immunology, Oncology +17
1–1 of 1